HIF-1α and VEGF expression correlates with thrombus remodeling in cases of intravascular papillary endothelial hyperplasia

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 12, 2013, Pages 2912-2918

  Kim, Sunzoo ^a   Jun, Jae Hun ^a   Kim, Jeongshik ^a   Kim, Do Won ^a   Jang, Yong Hyun ^a   Lee, Weon Ju ^a   Chung, Ho Yun ^a   Lee, Seok Jong ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Hif 1 ; Hypoxia; Intravascular papillary endothelial hyperplasia; Thrombus; Vegf

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CELL HYPOXIA; CELL PROLIFERATION; CHEMISTRY; CHILD; FEMALE; HIF-1Α; HUMAN; HYPERPLASIA; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SOUTH KOREA; THROMBOSIS; THROMBUS; UNIVERSITY HOSPITAL; VASCULAR ENDOTHELIUM; YOUNG ADULT;

HIF-1Α; HYPOXIA; INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA; THROMBUS; VEGF;

ADOLESCENT; ADULT; CELL HYPOXIA; CELL PROLIFERATION; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERPLASIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REPUBLIC OF KOREA; THROMBOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84888815082     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weedon D. Weedon's Skin Pathology. China: Churchill Livingstone publishers, 2009.
2. Hashimoto H, Daimaru Y and Enjoji M. Intravascular papillary endothelial hyperplasia. A clinicopathologic study of 91 cases. Am J Dermatopathol 1983; 5: 539-546.
3. Clearkin KP and Enzinger FM. Intravascular papillary endothelial hyperplasia. Arch Pathol Lab Med 1976; 100: 441-444.
4. Kumar V, Abbas AK, Aster JC, Fausto N. Robbins and Cotran Pathologic Basis of Disease. China: Saunders publishers, 2010.
5. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ and Bijnens AP. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008; 51: 1258-1265.
6. Northeast AD, Soo KS, Bobrow LG, Gaffney PJ and Burnand KG. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 1995; 22: 573-579.
7. Crivellato E, Nico B and Ribatti D. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett 2008; 269: 1-6.
8. Nishikori Y, Kakizoe E, Kobayashi Y, Shimoura K, Okunishi H and Dekio S. Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase. Arch Dermatol Res 1998; 290: 553-560.
9. Iijima K, Yoshikawa N and Nakamura H. Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse trans-cription-polymerase chain reaction assay. J Immunol Methods 1996; 196: 199-209.
10. Abdel-Majid RM and Marshall JS. Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol 2004; 172: 1227-1236.
11. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR and Sampsel JW. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002; 62: 7042-7049.
12. Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y and Vignaud JM. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 2002; 140: 320-328.
13. Moldovan NI and Asahara T. Role of blood mononuclear cells in recanalization and vascularization of thrombi: Past, present, and future. Trends Cardiovasc Med 2003; 13: 265-269.
14. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000; 157: 411-421.
15. Bruick RK and McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294: 1337-1340.
16. Lando D, Peet DJ, Whelan DA, Gorman JJ and Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295: 858-861.
17. Mizukami Y, Kohgo Y and Chung DC. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin Cancer Res 2007; 13: 5670-5674.
18. Ng I, Tan WL, Ng PY and Lim J. Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations. J Clin Neurosci 2005; 12: 794-799.
19. Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J and Yamamoto H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 1995; 270: 28316-28324.
20. Hopf HW, Gibson JJ, Angeles AP, Constant JS, Feng JJ, Rollins MD, Zamirul Hussain M and Hunt TK. Hyperoxia and angiogenesis. Wound Repair Regen 2005; 13: 558-564.
21. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.